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Abstract 
Pediatric sepsis is a major contributor to childhood morbidity and mortality. Tools for predicting 
sepsis in pediatric patients have had poor predictive ability nor been validated. Risk assessment 
screening tools are effective at earlier detection of sepsis. The implementation of an evidence-
based pediatric sepsis screening tool could reduce time to detect and diagnose severe sepsis so 
that patient treatment could occur earlier. This was a quality improvement project that evaluated 
a sepsis screening tool predictive validity at a children’s hospital.  
Keywords: sepsis, severe sepsis, screening tool, pediatric, child, risk assessment tool 
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Final Defense: Sepsis Screening Tool Assessment at Helen DeVos Children’s Hospital 
Pediatric sepsis is a major contributor to childhood morbidity and mortality (Schlapbach 
& Kissoon, 2018). According to Weiss et al. (2015), there is an 8.2%prevalence of pediatric 
severe sepsis in critically ill patients globally, with a hospital mortality rate of 25%. Despite 
global recognition as a problem, unclear sepsis definitions prohibit bedside clinicians from 
accurately identifying sepsis (Schlapbach & Kissoon, 2018). Tools for predicting sepsis in 
pediatric patients have poor predictive ability nor can evidence be found in the literature that 
they are validated. Systemic inflammatory response syndrome (SIRS) was used to define and 
predict sepsis in pediatric patients (Schlapbach & Kissoon, 2018).  However, this criterion had 
low specificity and of limited use to clinicians (Schlapbach & Kissoon, 2018). An evidence-
based pediatric sepsis screening tool is needed in order to initiate earlier diagnosis of sepsis and 
decrease the number of sepsis cases per year. The purpose of this quality improvement project 
was to assess and validate a pediatric sepsis screening tool in use at a freestanding children’s 
hospital in the Midwest (that referred to as CHM). 
Assessment of the Organizational 
An organizational assessment (OA) is a systematic process intended to evaluate the 
workflow and factors that affect the performance of an organization (Reflect & Learn, n.d.). 
From an OA, the organization can better understand areas of competence and areas needing 
improvement. The purpose of this OA was to analyze CHM using an OA framework. Primary 
stakeholders were identified, and strengths, weaknesses, opportunities, and the threats (SWOT) 
of the organization explored through a SWOT analysis. 
Framework for Assessment 
 The Canadian Foundation for Healthcare Improvement (CFHI) assessment tool 
FINAL DEFENSE 
  
   
6 
evaluates an organization’s capability for change, the strengths the organization possesses in 
implementing change, and how the organization can expand these strengths for improvements 
(CFHI, 2014). CFHI is guided by six core principles that were developed with the 
goal of supporting healthcare improvement. These factors include patient-centered and 
population-based care, evidence-based decision making, engaging a wide range of stakeholders, 
engaging participation from managers and providers, using an incremental process for large scale 
improvements, and viewing improvement as a collective learning process (CFHI, 2014). 
Appendix A depicts how these factors equally contribute to overall healthcare improvement 
(adapted from CFHI, 2018). The CFHI assessment tool analyzes how well organizations include 
each criterion to form suggestions for care improvements within the organization. 
CFHI recognizes that healthcare improvement requires collaboration from all levels of a 
system, including policy, organizational, clinical, and front-line staff (CFHI, 2014). Furthermore, 
CFHI also advises for operating in change cycles for improvements, rather than constant 
reorganizing to maintain stability for the organization. Finally, CFHI holds the stance that 
change within a level of a health system can lead to improvements at the clinical level, including 
patient health outcomes and hospitalization experiences (CFHI, 2014). 
Ethics and Protection of Human Subjects 
CHM and the GVSU Institutional Review Boards (IRB) determined the project to be 
quality improvement (see Appendix B and C).  
Stakeholders 
Key stakeholders are individuals affected by change within an organization, or 
individuals who have an interest in the project outcome (Moran, Burson, & Conrad, 2017). For 
the implementation of a pediatric sepsis screening tool at CHM, the key stakeholders were the 
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healthcare providers i.e., physicians, physician assistants, nurse practitioners, and nurses. 
Patients were also an important stakeholder, because patients are the highest priority when 
implementing a change that affects patient outcomes. Other stakeholders included the sepsis 
steering committee at CHM, and the electronic health record (EHR) technical employees who 
worked to implement the chosen screening tool into the EHR. Finally, another key stakeholder 
that is of importance to note is CHM as an organization. It was pertinent the organization 
understood the importance of adding a pediatric screening tool, because there could have been a 
monetary cost to adding the tool into the EHR. 
SWOT 
 A SWOT analysis is a tool used to analyze strengths, weaknesses, opportunities, and 
threats to a phenomenon of interest (Moran et al., 2017). Internal analyses include identifying 
attributes and evaluating successes and weaknesses within the organization. External analysis 
includes evaluating environmental influences and identifying opportunities or obstacles for the 
phenomenon of interest (Moran et al., 2017). The phenomenon of interest for this SWOT 
analysis was infection (sepsis). Appendix D displays the SWOT analysis discussed below. 
 Strengths. Strengths of CHM included their interprofessional collaboration as well as 
utilization of a sepsis steering committee. Along with this, building on existing sepsis protocols 
within the adult and neonatal populations aided in collaboration for this pediatric sepsis 
screening tool. Finally, a strength of CHM was their ranking as one of the best children’s 
hospitals in six specialty areas for 2018 by U.S. News and World Report (Jensen, 2018). This 
shows what others perceive as CHM strengths, which is an important part of this analysis (Moran 
et al., 2017). 
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 Weaknesses. Weaknesses of CHM included the current state of the pediatric sepsis 
screening tool being on paper and not embedded in the EHR. This caused tension with RNs, 
because it was an added task for the RNs to fill out a paper tool rather than within the EHR. 
Another weakness was collating paper documents. It was time consuming to evaluate use of the 
screening tool on paper compared to use in an EHR, which can generate a report. Furthermore, it 
was difficult to ensure screening tools were timestamped correctly when on paper, if RNs did not 
chart the exact time the screen was performed. Finally, the timing of the paper sepsis screening 
tool was initiated shortly after a new EHR was initiated at CHM. This caused RN dissatisfaction, 
confusion and errors, as RNs were overloaded with change. This led to a lack of proper screening 
and/or proper documentation of sepsis screening. 
 Opportunities. One opportunity was the CHA sepsis collaborative. This is a 
collaborative with other children’s hospitals works together to find the best solution for sepsis 
screening. Another opportunity was the ability to work within the new EHR to initiate a tool 
within the electronic documentation platform to screen for pediatric sepsis. The EHR in use at 
CHM allows for creation and customization of tools and would support the pediatric sepsis 
screening tool built within the EHR. 
 Threats. Threats to this project were deadlines. Part of the CHA collaborative requires 
that data be entered by certain deadlines. The first deadline was October 1, 2018 when 
retrospective data must be entered so that CHM could continue as a CHA collaborative member. 
This was a difficult process at CHM, because retrospective data had to be retrieved from the 
older version of the EHR, and there had been difficulty generating reports. Another threat to this 
project was the rapid nature of the work being done without considering all the factors to create 
change and be successful, such as the lack of an evidence-based tool used within CHM. Without 
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evidence to support a tool, data collected may not be valid, which could threaten the work that 
had been done at CHM. 
Clinical Practice Question 
The following clinical questions were addressed. “Did the current pediatric sepsis 
screening tool in use at CHM identify patients at risk for sepsis?” As well as, “Did the sepsis 
screening tool used initiate interventions (i.e. fluid boluses and antibiotics) earlier than when 
compared to no tool being used?” 
Review of the Literature 
Method 
Search methods. A comprehensive electronic search was conducted in the CINAHL, 
PubMed, and Web of Science electronic databases and was limited to reviews in the English 
language during the period of 2013 to 2018. Keywords were sepsis, tool, pediatric, neonate, 
child, and early warning score. 
Inclusion and exclusion criteria. The inclusion criterion for the literature review search 
included articles that were published from 2013 to present. The type of studies included were 
meta analyses, randomized control trials (RCTs), and systematic reviews. The search was also 
limited to peer-reviewed journals. Exclusion criteria included clinical trials, pilot studies, 
observational studies, and articles published greater than 5 years ago. 
Population. Included were samples that featured sepsis populations in acute care 
settings. For the purpose of this review, a pediatric population was defined as patients zero to 18 
years of age, including the neonatal period (0-28 days). After limited research presented on 
pediatric sepsis independently, articles that discussed adult sepsis protocols while acknowledging 
pediatric differences were also included in this review. 
FINAL DEFENSE 
  
   
10 
Intervention. Interventions for this literature review targeted sepsis screening tools in the 
acute care setting. This excluded studies that only analyzed biomarkers or medication therapies 
for the treatment or prevention of sepsis. Screening tools intended for use in outpatient settings 
were excluded. 
Comparison. The comparison group for this was pediatric acute care settings that did not 
utilize a pediatric sepsis screening tool. This included settings that utilized an adult sepsis 
screening tool on a pediatric population. Also included were pediatric sepsis screening tools in 
use that were not supported by an evidence-base. 
Outcome. The intended outcome was increased early identification of pediatric sepsis. In 
time, this could lead to decreased morbidity and mortality rates caused by pediatric sepsis. This 
also, could lead to increased quality of life outcomes for survivors of pediatric sepsis. Currently, 
17% of pediatric sepsis survivors globally have at least moderate disability after surviving sepsis 
(Weiss et al., 2015).  
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)  
 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guideline served as the framework for this review (Moher et al., 2015). The search initially 
yielded 243 CINAHL, PubMed, and Web of Science articles. Nine duplicates were found, with 
234 articles remaining. Each paper was screened using inclusion and exclusion criteria according 
to PRISMA criteria (Moher et al., 2015) (see Appendix E). Review of titles and abstracts 
resulted in removal of 214 articles that did not meet the inclusion criteria. An additional 16 
articles were excluded after in-depth examination of content, as did not meet inclusion criteria. 
The remaining four articles were included in this review. 
Summary of Results 
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Four papers met inclusion criteria and were included in the review (see Appendix F). 
These four studies included three systematic reviews and one RCT.   
Study characteristics. Three of the articles were conducted in the United States (Davis 
et al., 2017; Lake, Fairchild, & Moorman, 2014; & Roney et al., 2015 and one in Australia 
(Paliwoda & New, 2015). All of the studies took place in the acute care hospital setting. One 
article examined heart rate activity in neonatal infants as a marker for neonatal sepsis (Lake, 
Fairchild, & Moorman, 2014). The other three articles systematically reviewed sepsis protocol 
screening tools for the neonatal, pediatric, and adult populations (Davis et al., 2017; Roney et al., 
2015; & Paliwoda & New, 2015). All of the studies involved analysis of screening for earlier 
identification of sepsis.  
Intervention and comparison characteristics. Each of the reviews reported on efficacy 
of screening for sepsis and protocol to identify sepsis-based articles within each review’s 
inclusion criteria (Davis et al., 2017; Roney et al., 2015; & Paliwoda & New, 2015). One review 
evaluated a sepsis screening tool based on mortality predictive value and/or reduction, 
emergency calls, and utilization of a rapid response team (Roney et al., 2015). Another compared 
neonates whom received an intervention based upon use of a sepsis screening tool (Paliwoda & 
New, 2015). The third compared previous sepsis guidelines to more recent quality improvement 
initiatives to identify sepsis sooner (Davis et al., 2017). The RCT compared heart rate 
characteristics (HRC) of neonates with and without confirmed sepsis (Lake, Fairchild, & 
Moorman, 2014).   
Measures.  A variety of outcome measures were used. The outcomes in the systematic 
reviews were earlier identification of patient deterioration and decreased time to intervention 
(Davis et al., 2017; Roney et al., 2015; & Paliwoda & New, 2015). The RCT measured risk 
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markers for proof of improved clinical outcomes, such as analyzing HRC as a predictor for 
sepsis development and how much monitoring HRC improves clinical outcomes for septic 
neonates by means of analyzing mortality rate (Lake, Fairchild, & Moorman, 2014).  
Efficacy of earlier identification and decreased time to intervention. Earlier 
identification of patient deterioration had variation in measures within each review. One review 
found use of the modified early warning scoring (MEWS) screening tool effectively detected 
earlier identification of sepsis as evidenced by a significant rate in mortality reduction (Roney et 
al., 2015). This review also analyzed MEWS effectiveness for early sepsis identification by a 
decrease in rapid response team utilization. Davis et al. (2017) also discussed efficacy of a tool 
by analyzing mortality rate. This review found after initiating a trigger tool for sepsis, mortality 
rates decreased for both the pediatric and neonatal populations. One study within the review 
discussed a mortality rates decreased from 38% to 8% after initiating the sepsis tool. Another 
study discussed within this review had a mortality rate decrease from 20% to 7% (Davis et al., 
2017). After performing a systematic review on early warning tools (EWTs) Paliwoda and New 
(2015) applied the new tool (EWT) to old charts of children who were identified with pediatric 
sepsis. As a result of the EWT, 47% of neonates would have received an intervention for sepsis 
(Paliwoda & New, 2015).  
 Efficacy of HRC risk markers. Lake, Fairchild, and Moorman (2014) discussed risk 
markers for proof of improved clinical outcomes. To detect predictive values of sepsis risk, 
antibiotic initiation and use in neonates with and without HRC monitoring were analyzed. The 
RCT looked at mortality rate differences between use or non-use of the HRC, and the mortality 
rate decreased in the HRC use group from 10.2% to 8.1% (p=0.04). Furthermore, in low birth 
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weight neonates, the mortality rate decreased from 17.6 to 13.2% (p < 0.02) with use of HRC 
monitoring (Lake, Fairchild, & Moorman, 2014).  
Evidence for Project  
Findings of this review suggested use of a screening tool for earlier identification and 
initiation of interventions for pediatric sepsis improved patient outcomes. Factors to be included 
in a sepsis screening tool include respiratory rate, heart rate, blood pressure, temperature 
(specifically hypothermia or hyperthermia), altered mental status, and capillary refill (Davis et 
al., 2017; & Roney et al., 2015). Furthermore, it was suggested that neonates have more specific 
criteria for the screening tool, such as HRC, glucose level, and behavioral monitoring (e.g., 
lethargy or poor feeding) (Paliwoda & New, 2015; & Lake, Fairchild, & Moorman, 2014).  
In addition to the neonatal population, units treating a specific type of pediatric patient 
population should have more specific criteria for the particular sub-population (Roney et al., 
2015). For example, pediatric oncology/hematology patients may have indicators or a narrower 
index for the criteria listed above when screening for sepsis than the general pediatric population. 
This is under development and needs additional research (Roney et al., 2015).  
There are limitations specific to the review that warrant discussion. First, as sepsis is an 
ever-evolving topic, there was limited data in the past 5 years regarding reliability and validity of 
pediatric sepsis screening tools. The studies in this review had small sample sizes and similar 
criterion. However, no standardized pediatric sepsis screening tools were used in the four studies. 
Although this is more of a limitation of current research rather than a reflection of this review.  
Pediatric sepsis is a significant problem that often leads to devastating outcomes. Earlier 
identification and intervention may be a solution. Without use of an evidence-based pediatric 
sepsis screening tool, early signs of sepsis in this population are often missed. This review 
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highlighted pediatric sepsis screening tools as an efficacious approach to earlier identification of 
sepsis.  
Results suggest that the current evidence is in favor of utilizing a screening tool for sepsis 
designed for use within the pediatric population as a gold standard for clinical practice in the 
acute care hospital setting. Use of this type of tool has the potential to improve patient outcomes 
and reduce mortality rates in the pediatric population.   
Phenomenon Conceptual Model 
 Conceptual models are useful as guides for understanding a phenomenon. The 
phenomenon of interest for this quality improvement project was infection, more specifically 
sepsis. A conceptual model that was used to provide structure for this phenomenon of interest is 
the Center for Disease Control and Prevention (CDC) Infectious Disease Framework (IDF) 
(CDC, 2011). IDF is broken down into three elements that guide the process of disease 
prevention (see Appendix G). The model was designed to provide a map for improving and 
preventing infectious diseases. The IDF also acts as a guide for creating evidence-based policies 
(CDC, 2011).  
 Element one. The first element of IDF focuses on strengthening public health 
fundamentals, including surveillance of infectious disease (CDC, 2011). Surveillance of 
infectious disease drives public health actions. As suggested by the first element of IDF, 
surveillance can lead to the advancement of workforce development to prevent infectious 
diseases by improving knowledge on sepsis and improving earlier detection of sepsis (CDC, 
2011).  
 Element two. The second element of IDF builds upon the first, in that it discusses 
implementation of interventions to reduce infectious diseases (CDC, 2011). This element 
FINAL DEFENSE 
  
   
15 
specifically discussed identifying and validating tools for disease reduction. This is what the 
foundation of this project was built upon; validating a sepsis risk assessment tool in order to 
reduce high-burden infectious diseases through earlier identification (CDC, 2011).  
 Element three. Finally, the third element of IDF focuses on developing policies to 
prevent, detect, and control infectious diseases (CDC, 2011). Validating a sepsis risk assessment 
tool covers the prevention aspect of this element, because it aligns with the CDC’s position of 
evidence-based detection policies. However, controlling this type of infectious disease is a step 
beyond what this specific project covered. Beyond this project, policies can be developed and 
implemented within CHM based on evidence. This could include a sepsis bundle for initiation of 
interventions once sepsis is diagnosed.  
Project Plan 
Purpose of Project and Objectives 
The overarching goal of the project was to improve pediatric sepsis detection using a 
screening tool. The current tool used at CHM underwent expert review, thus, it had content 
validity. Construct validity to determine if the screening tool detects sepsis never occurred. Thus, 
the project examined if the sepsis screening tool would detect risk of sepsis. 
Design for the Evidence-based Initiative 
This project was a quality improvement project focused on tool examination to validate 
the sepsis screening tool effectiveness at predicting and identifying risk of sepsis. The project 
also examined if use of the screening tool improved time to treatment (i.e. fluid boluses and 
antibiotics) in those with a sepsis diagnosis compared to when no tool was used.  
Quality improvement projects involve systematic activities designed to monitor, assess, 
and/or improve an organization’s quality of healthcare (Health Resources and Services 
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Administration, 2011). To examine if the screening tool detected risk of sepsis, a cohort of 
patients diagnosed with sepsis were examined using the current sepsis screening tool just prior to 
the patient demonstrating signs of sepsis. To examine time to intervention (i.e. fluid boluses and 
antibiotics), the actual time administered was examined in those who used the screening tool 
then compared to those who did not use the screening tool.   
Setting  
The setting for this project was a freestanding children’s hospital in the Midwest (CHM). 
This included units with specialties in hematology, oncology, cardiology, respiratory, surgical, 
and behavioral health.  Administrative approval to conduct the project was obtained from the 
organization (see Appendix H).    
Participants   
 Patients with a diagnosis of severe sepsis in the hematology, oncology, cardiology, 
respiratory, surgical, or behavioral health units were included.  The sample size was 122 patients 
to examine the detection of risk; and 167 to examine time to intervention (122 with no screening 
tool and 45 with a screening tool).  
Model Guiding Implementation 
 The model guiding implementation of this project was the Institute for Healthcare 
Improvement (IHI) Plan Do Study Act (PDSA) cycle (see Appendix I).  This model is useful for 
documenting and testing a proposed change (IHI, 2017). At CHM, the PDSA model is well 
recognized and used, which was a big draw for using it within the context of this project.  
Plan. The plan phase of PDSA includes stating the question and a prediction for what 
will happen, developing a plan to test the change, and identifying what data needs to be collected 
(IHI, 2017). The clinical question was, as previously discussed, “Did the current pediatric sepsis 
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screening tool in use at CHM identify patients at risk for sepsis?” As well as, “Did the sepsis 
screening tool used initiate interventions (i.e. fluid boluses and antibiotics) earlier than when 
compared to no tool being used?” A prediction for what will happen was that time to detection of 
sepsis will be quicker with use of this tool and better overall sepsis outcomes will ensue. A plan 
was developed to validate the screening tool for sepsis included analyzing patient charts of those 
diagnosed with severe sepsis to determine predictive ability of the tool. Identification of data 
collected is discussed within the measures section of the paper.  
Do. The next step of PDSA is the do stage. During this stage, a test is carried out on a 
small scale with data collection and analysis (IHI, 2017). This phase was carried out by 
performing a small 5-chart audit of pre-tool patients diagnosed with severe sepsis. This small 
sample provided data to discover the amount of time needed to perform a chart audit in order to 
determine a sample size for the tool validation, with over 100 charts likely to be needed for 
statistical models to examine validity. 
Study. During the study phase of PDSA, results are analyzed and compared to original 
predictions (IHI, 2017).  After deciding on a sample size, the chart audits occurred on patients 
both before implementation of current tool and after tool was implemented at CHM of patients 
with diagnoses of severe sepsis. During this phase, data were analyzed to determine if the current 
tool at CHM detected sepsis risk or not.   
Act. In this stage of PDSA a decision has to be made to adapt, adopt, or abandon the 
change before starting a new cycle in the plan phase of PDSA (IHI, 2017). Adapting the change 
involves making modifications and running another test. Adopting the change involves testing 
the change on a larger scale. Abandoning the change involves changing the idea altogether (IHI, 
2017). The anticipated outcome was that during this phase CHM would be adopting the change.  
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Implementation Steps and Strategies 
 According to Powell et al. (2015), there are evidenced-based implementation strategies to 
be used within the implementation of a project. Each will be discussed.  
Readiness assessment and identify barriers. First, a strategy that was used within the 
context of this project was assessment of readiness and identifying barriers to the project (Powell 
et al., 2015). This was conducted during the organizational assessment and SWOT analysis. The 
assessment discovered implementation strategies in place that further assisted with this project.  
Capturing and sharing knowledge and creating a collaborative. These strategies 
included capturing and sharing knowledge, creating a learning collaborative, organizing 
implementation team meetings, and using an implementation advisor (Powell et al., 2015). 
Capturing and sharing knowledge, as well as creating a learning collaborative, are both aspects 
of ongoing implementation strategies at CHM. CHM is part of a greater sepsis collaborative put 
on by the Children’s Hospital Association (CHA). This collaborative has a goal of reducing 
hospital-acquired severe sepsis and sepsis mortality by 75% by the year 2020 (CHA, 2018). By 
joining this collaborative, CHM became part of an all-teach, all-learn interdisciplinary team 
which allowed them to view current research other hospitals are doing in order to see what is 
working for them. After joining this collaborative, CHM also created a sepsis steering committee 
to work as the driving force for the organization; this fulfilled the implementation strategy of 
organizing a team and team meetings (Powell et al., 2015). Finally, this committee appointed an 
implementation advisor to direct the group meetings.  
Consultation and tools for quality improvement. Beyond these initial strategies 
already in place, the project purposely re-examined the implementation, provided ongoing 
consultation, and developed tools for quality monitoring (Powell et al., 2015). Purposely re-
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examining the implementation of a risk-assessment tool took place by the DNP student, because 
CHM initially implemented the risk assessment tool without first ensuring it was evidence-based. 
Next, the DNP student provided ongoing consultation with CHM based on findings in literature 
and work found through chart audits to validate the risk assessment tool. Finally, the DNP 
student developed tools for quality monitoring through a table of measures and codebook used to 
conduct chart audits.  
Measures 
  Measures for gauging the project success included system and pediatric patient 
measures. System measures were admission to ICU, time to admit to ICU after diagnosis, time to 
antibiotic initiation, time to fluid bolus, time to “trigger” tool, and time to sepsis huddle. The 
patient measures were tachycardia, bradycardia, hypotension, fever, hypothermia, current use of 
steroids, altered mental status, the presence of chills, capillary refill greater than 3 seconds, 
mottled or cool extremities, presence of neck stiffness, “flash” capillary refill less than 1 second, 
and presence of neutropenia (ANC less than 500). Definitions for each measure are shown in 
Appendix J and K. A flow chart further defining triggers that prompt measurement is shown in 
Appendix L.  
Items on the screening tool for sepsis were selected by CHM based on information from 
the CHA (2018) sepsis collaborative. To assure screening tool items were evidence based, 
literature supporting each item on the tool are shown in Appendix M. In addition, content experts 
from the CHM sepsis steering committee reviewed each item on the tool and reconfirmed usage.  
Data Collection Procedures 
 Data were collected by the DNP student through chart reviews in the EHR as described in 
Appendix J (January 1, 2017 through August 31, 2018). CHM changed to a new EHR in 
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November of 2017 thus, data prior to that date were from the old platform. Data were collected 
from patients who had a diagnosis of severe sepsis. This included the old EHR dates of January 
1, 2017 through October 31, 2017 and new EHR dates of November 1, 2018 through August 31, 
2018. Data were kept on a secure network password protected internal drive at the site, 
accessible by members on the team from CHM.   
Data Management   
 First, data were collected from the EHR in an Excel datasheet stored on the CHM internal 
drive. Next, data in the excel datasheet was de-identified. After de-identified, the student and 
biostatistician analyzed the data using Statistical Analysis System (SAS) version 9.4 (statistical 
software).  
Analysis  
Data were analyzed using factor analysis (shown below) to determine if the screening 
tool detected sepsis prior to the sepsis diagnosis. For time to intervention, a pre- and post-tool 
comparison provided data on if time to intervention improved after initiation of screening tool 
usage used t-test or chi-square, with a p-Value of 0.05 demonstrating a difference.  
 Factor analysis. A plan was devised to use factor loading of the following variables: did 
patient go to ICU, time to ICU, time to antibiotic initiation, time to fluid bolus, time to “trigger” 
tool, time to sepsis huddle, and presence of tachycardia, bradycardia, hypotension, fever, 
hypothermia, current use of steroids, altered mental status, chills, capillary refill greater than 3 
seconds, mottled or cool extremities, neck stiffness, "flash" capillary refill less than 1 second, or 
neutropenia was conducted. Construct validity testing of the unidimensionality of the risk of 
sepsis variables using structural equation modeling (SEM) techniques of exploratory factor 
analysis (EFA) and confirmatory factor analysis (CFA) with principal axis factoring varimax 
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(orthogonal) rotation was assessed. SEM is an analytical tool that provides an alternative to 
experimentation for examining the plausibility of hypothesized models (Kline, 2005). Missing 
data were checked and corrected if possible, otherwise cases with missing data were removed 
prior to analysis. Random assignment to two datasets occurred splitting data in half, one half 
used for EFA and the other CFA. Cross-validation of a dataset strengthened predictive validity 
(Vandenberg, 2006).  
 Exploratory analysis. Sampling adequacy tests was done using the Kaiser-Meyer-Olkin 
(KMO) and Bartlett test. KMO is a measure of sampling adequacy comparing the magnitudes of 
the observed correlations coefficients to the correlation coefficients, which should be greater 
than .50 for a satisfactory factor analysis to proceed (Kline, 2005). Bartlett is an indicator of the 
strength of the relationship among variables testing if the correlation matrix is uncorrelated and 
whether the correlation matrix is an identity matrix; a significance level must be small enough to 
conclude that the association of the relationship among the variables is strong (Kline, 2005). If 
significant then the correlation matrix is not an identity matrix, structure exists and the strength 
of the relationship among the variables is large enough for factor analysis (Kline, 2005). 
Confirmatory analysis. A two-step approach was taken, testing the measurement model 
for fit before testing the full structural model (Joreskog & Sorbom, 2004). Two indictors were 
used to examine CFA: comparative fit index (CFI), a relative fit index with values ≥ .95 
indicating good fit; and the root mean square error of approximation (RMSEA), an indicator of 
the discrepancy in fit per degree of freedom adjusted for sample size, with values smaller than 
0.08 providing a reasonable approximation of the factor loading (Kline, 2005). If the model 
converges, and the fitting measures indicated a good fit (RMSEA; CFI), confirmation of a 
relationship will exist. 
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Resources & Budget  
 Resources for this project included the DNP student, the sepsis steering committee, 
clinicians, and RNs. Further resources for this project included organizational support such as the 
facility itself, computers, and the ability to print the pediatric sepsis paper tools. The DNP 
scholarly project to validate the sepsis screening tool included a budget (see Appendix N). The 
DNP student filled a need for the organization at no cost other than use of staff time to provide 
information or data related to the project. The site staff involved in this project had approved 
time to put towards this project as part of their roles.   
Timeline  
 Institutional Review Board (IRB) approvals were obtained from the site and university. 
The groundwork (i.e. performing an organizational assessment and completing a literature 
review) for the project was completed on July 28, 2018. The project proposal took place on 
November 7, 2018. Upon approval, data collection began and was collected through February 1, 
2019 followed by data analysis. Findings were disseminated to key stakeholders by March 4, 
2019. The final project defense took place on April 8, 2019. The time line for this project is 
shown in Appendix O.  
Results 
Descriptive statistics were run and a pre- and post-tool comparison were utilized to 
provide data to determine if time to intervention improved after initiation of screening tool usage 
using t-test or chi-square, with a p-value of 0.05 demonstrating a difference were used as SEM 
was found to be insufficient.  
Patient Characteristics 
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The characteristics of patients in the audit are shown in Appendix P. Mean age was 
7.05(SD 6.05) years with a range of 0.02-20.57. There were nearly even numbers of males 
(55.7%; n = 93) and females (44.3%; n = 74); most were Caucasian (60.5%; n = 101) or African 
American (6.2%; n = 27); and 13.8% (23) were Hispanic. Length of stay was a median of 10.5 
(IQR 4.94 –19.14) and 6% (n = 10) had hospital acquired sepsis. 
Audit of Clinically Derived Time Zero (CDTZ) 
Patients audited during data collection all had a Clinically Derived Time Zero (CDTZ) – 
this was determined by a physician within the organization who retrospectively determined the 
time when each patient first showed signs of severe sepsis. CDTZ acted as “time zero” for 
determining the length of time it took for fluid, antibiotics, and transfer to ICU to be initiated. 
CDTZ also acted as the last point where the sepsis screening tool should have flagged in order to 
be still considered “screening” for the detection of sepsis.  
Overall 71.7% (n = 119) would have flagged within 24 hours. Of these patients, 34.8% 
(58) would have flagged before or at CDTZ. However, 28.3% (n = 47) of patients would not 
have flagged within 24 hours of clinically derived time zero using the tool (see Appendix Q). 
Frequency of High-Risk Factors 
 The sepsis screening tool took into account certain high-risk factors to be considered 
when screening patients for sepsis. These factors would not in and of themselves flag the tool but 
having high-risk factors in addition to flagging steps 1 and 2 on the tool would initiate a call for a 
provider to come assess the patient.  
Of the high-risk factors evaluated, when the factor occurred, documentation was not 
always easily found in the audit (see Appendix R). For example, “Leukopenia, Leukocytosis, or 
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Bands >10% in the last 12 hours” was only credited if the labs were documented before or at 
clinically derived time zero. If labs were drawn after CDTZ of sepsis, it was considered as not an 
early enough indicator to flag the tool. Further, it was difficult to document “no” for a high-risk 
factor unless it specifically stated somewhere within a patient’s chart that they patient did not 
have the factor. For example, not a single chart specifically stated that a patient “did not” have 
asplenia. Due to this, all patients were considered “not documented/unclear” besides the 2 whose 
chart explicitly stated they did have asplenia. This was a common problem in auditing the high-
risk factors of where to find in the chart an actual documentation of the risk factor. 
Abnormal High-Risk Condition: ANC 
A particular high-risk factor added for immunocompromised patients was calculating of 
the ANC. The ANC was specifically analyzed in relation to being less than 500 for greater than 7 
days. For the purpose of this analysis, ANC below 500 in and of itself was analyzed as a high-
risk factor, regardless of the number of days it had been present. As shown in Appendix S, of the 
times an ANC value (N = 47) was calculated, the median 35.57, was below 500.  
Time from Status Change to ICU admission, Antibiotic, and Fluid initiation 
Appendix T shows a decrease in median time to patient transfer to ICU (2.24) and fluid 
administration (0.17), while time to antibiotic treatment increased (0.29).  There was not 
sufficient evidence to say that time SEPSIS was flagged improved when comparing before to 
after tool use (p=0.19). 
Clinical Status Symptom/Sign that Flagged the Tool 
 As shown in Appendix U, the top five clinical status symptoms/signs that flagged the tool 
were tachycardia (65.3%, n = 109), fever (62.9%, n = 105), altered mental status (38.9%, n = 
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65), capillary refill greater than 3 seconds (18.6%, n = 31), and hypothermia (18.0%, n = 30). 
Mottled and/or cool extremities and neutropenia were also above 10% occurrence. 
Age Range Parameters 
 Appendix V shows the mean or IQR for heartrate, fever, and blood pressure by age 
groups and should be interpreted within the parameters expected of each age group. For example, 
the mean heart rate for >1 – 2 months and 3 – 11 months did not meet parameters for sepsis 
criteria. Furthermore, no age group had an average systolic blood pressure that would have met 
the criteria for that age group. It also is important to note that diastolic values were used for the 
purpose of this calculation, but the tool did not have parameters for the diastolic blood pressure 
values.  
Factors that Flagged the Tool Before- or At- CDTZ 
 As shown in Appendix W and X, the top five clinical status high risk factors that flagged 
the tool before or at clinically derived time zero were tachycardia (84.5%, n = 49), fever (79.3%, 
n = 46), altered mental status (65.5%, n = 38), CNS dysfunction (51.7%, n = 30), and presence of 
a central line (36.3%, n = 21). Capillary refill greater than 3 seconds, leukopenia leukocytosis 
Bands >10% in the last 12 hours, hypotension, and hypothermia were also above the 20% 
occurrence rate. 
Discussion  
Current State 
This project found that the current tool use at CHM to detect risk of sepsis needs further 
examination of validity and reliability.  This is supported by the current state of the literature in 
that no evidence-based sepsis screening tools are tailored for pediatric populations, as only 
content-reviewed factors to screen for when evaluating for sepsis in pediatrics (Davis et al., 
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2017; Lake, Fairchild, & Moorman, 2014; Paliwoda & New, 2015 & Roney et al., 2015). As 
there are no other tool, the creation and testing of a tool to detect risk of Sepsis is needed before 
a tool will be validated for evidence-based use.   
Key Findings 
 Although the anticipated outcome of tool construct validation was not met, there were 
several strengths found within this project. First, this is a much-needed area of study and any 
research findings to add to the current state of literature aid in shaping future tool validation. 
Second, a decrease in median time to ICU transfer and fluid bolus initiation were found when 
comparing pre- to post- tool implementation. This shows an improvement in a critical time-
sensitive component of treating sepsis that is dependent on initially detecting sepsis through a 
screening tool. Thirdly, this study spoke to what the top clinical status signs/symptoms were in 
severe sepsis patients, this is useful information when deciding where to go next in configuring a 
tool that has construct validity. Finally, this project also was able to evaluate age-specific 
parameters for clinical status signs/symptoms such as heart rate, fever, and blood pressure. This 
information is also useful when determining next steps for a sepsis screening tool and could be 
used in future research.  
Limitations  
 This project had a fairly short implementation period and small sample size. Although 20 
months of data were used, there were still only 167 patients that met criteria of a severe sepsis 
diagnosis included in this project. Due to this, SEM analysis was not able to be performed, which 
could have been an advantageous statistical analysis to run for this type of project. Another 
limitation is the relatively small sample size of post-tool implementation patients (n=45). Time 
constraints for data collection, as well as not enough collated data on severe sepsis diagnosed 
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patients led to this smaller sample size. Another limitation was the lack of current evidence in 
literature to support any pediatric sepsis screening tool, let alone this specific tool.  Finally, it is 
important to note that this project took place during a transition period from one EHR to another. 
Therefore, it is possible that different results could ensue as time goes on with longer EHR use as 
some results could have been due to a lack of understanding on how and where to properly chart 
assessments within the EHR.  
Implications for Practice and Further Study in the Field 
 As previously discussed, the top five clinical status that flagged the tool were 
tachycardia, fever, altered mental status, capillary refill greater than 3 seconds, and hypothermia. 
These factors appear to be the most useful in identifying pediatric sepsis and perhaps another 
trial on a sepsis screening tool with these specific factors laid out in a different step-wise 
configuration would be worth analyzing. For example, step 2 (related to temperature of the 
patient) of the tool was often the last to flag. Thus, it may be worth reconsidering what factors 
are analyzed within step 2 of the tool or even worth considering combining step 2 and 3 of the 
tool into one category and then only enlisting a two-step function to flag the tool. It is also 
possible that a temperature was not taken frequently enough on patients; if this is the case than 
revisiting nursing assessment protocols for temperature frequency or critical thinking skills 
related to when obtaining a temperature is indicated may need to be discussed.  
Additionally, further exploration of the age-specific parameters for vitals needed to flag 
the tool is needed. Specifically, definitions of hypotension in all age groups and heartrate in 
infants less than one year should be considered. Another indicator that may need to be 
additionally added to a pediatric sepsis screening tool is evaluating both systolic and diastolic 
blood pressure values, and not only systolic values as the current tool does. Another indicator 
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that a future study may want to evaluate is respirations per minute, peripheral capillary oxygen 
saturation (Sp02), and/or hypertension. These were values that were often noticed outside of 
normal parameters on patients, although they were not values collected or evaluated by the 
current sepsis screening tool.  
Another aspect to consider in future studies is a better definition of Central Nervous 
System (CNS) dysfunction. This is a high-risk factor on the current screening tool that was found 
to be in the top 5 indicators of patients that flagged the tool before or at CDTZ. It may be worth 
considering redefining assessment standards for this patient population, as well as defining how 
these patients exhibit altered mental status compared to patients without CNS dysfunction.  
 Finally, a future project may consider combining risk assessment tools in the pediatric 
population into one cohesive tool. Currently at CHM there are several pediatric screening tools 
that assess for different problems, however, many of them have overlapping factors being 
assessed. It may be worth considering a way to combine these tools into one seamless tool that 
would have an algorithm to delineate which illness is detected based on the clinical status 
signs/symptoms found.   
Dissemination of Results  
Outcomes of this project were disseminated. First, tools for quality monitoring (table of 
measures and codebook used to conduct chart audits) and findings were distributed to CHM at 
the end of the project for use within the organization and collaborative. Second, findings were 
presented at the student’s oral defense on April 8, 2019. Third, the final project defense paper 
was posted on Scholarworks and can be accessed by anyone who is interested. Fourth, findings 
will be presented at the organization’s research council poster presentation on April 9, 2019. 
Fifth, findings will be presented to the sepsis steering committee at their May 6, 2019 meeting.  
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Sustainability Plan 
 Sustainability of this DNP project included the following. First, the sepsis steering 
committee chair will continue to monitor the effectiveness of the screening tool after the 
completion of this project. Second, the sepsis screening tool was embedded into the EHR at 
CHM on January 3, 2019 and will no longer be used as a paper tool, which makes for easier 
monitoring of tool effectiveness and sepsis detection. This should also increase RN compliance 
and morale towards the tool, because this eliminated the need for an extra step outside of 
electronic charting. A new policy will not be needed at CHM. However, a new build was needed 
in order for the screening tool for sepsis to be embedded into the EHR. This required IT 
involvement with the EHR company, as well as assistance from the CHA collaborative. The 
process for this new construct to be built into the EHR was completed as previously stated on 
January 3, 2019 making ongoing monitoring of this tool easier at CHM.  
Conclusion  
 CHM sought to validate a sepsis screening tool currently in use for evidence-based use. 
An organizational assessment of the current policy and practice surrounding use of the sepsis 
screening tool combined with a literature review on sepsis screening tools, identified the current 
sepsis screening tool had content validity but still needed construct validity. Two theoretical 
frameworks and one theoretical model were used to understand the phenomenon and conduct a 
plan to validate the sepsis screening tool. Pre- and post-tool chart audits were performed to 
implement this tool validation plan. Data collection occurred over two months including patients 
from January 2017 through August 2018. Despite being unable to provide construct validity for 
this pediatric sepsis screening tool, individual factors within the tool were able to be evaluated 
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and future studies should build upon this research in order to work towards validating a pediatric 
sepsis screening tool for evidence-based use.  
Reflection on DNP Essentials 
The American Colleges of Nursing (AACN) requires proficiency from DNP students in 
the following 8 competencies which make up the foundation for advanced practice nursing roles. 
Each are reviewed below.  
Essential I: Scientific Underpinnings for Practice 
 The DNP can integrate science using science-based theories and concepts to determine 
the significance of phenomena, as well as develop and evaluate outcomes of new practices based 
on evidence to alleviate or enhance the phenomena (AACN, 2006). This essential was achieved 
through this project by performing a literature review and using the knowledge gained from this 
review to improve care. Additionally, frameworks were utilized for implementing and guiding 
change.  
Essential II: Organizational and Systems Leadership 
 The DNP can develop and evaluate care delivery approaches that meet the needs of 
patient populations based on evidence-based findings in nursing science and other clinical 
sciences (AACN, 2006). This essential was achieved through this project by evaluating a tool 
that enhances care provided to the pediatric population. Furthermore, developing and evaluating 
cost-effectiveness is another aspect of this essential that was met by developing a budget for this 
project and monitoring the project’s cost effectiveness.  
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice 
 The DNP can translate research into evidence-based practice through use of analytical 
methods to appraise existing literature, designing and implementing processes to evaluate 
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outcomes of practice, and apply relevant findings to develop and improve practice guidelines 
(AACN, 2006). This essential was achieved through this project by using analytic methods to 
evaluate literature regarding the best evidence for sepsis screening in pediatric populations. The 
project included designing a process to evaluate the effectiveness of the current sepsis screening 
tool in place. Furthermore, relevant findings were disseminated to improve practice guidelines 
for use of the tool.  
Essential IV: Information Systems Technology 
 The DNP is proficient in use of and evaluation of information systems technology 
resources to support practice and care. This includes related ethical, regulatory, and legal issues 
related to use of information and systems technology (AACN, 2006). Through this project, this 
essential was met by utilizing and navigating two different EHRs to gather pre- and post-tool 
data. E-mail was used for communication with key stakeholders for progress updates and 
additional resources. Excel was used for organizing and analyzing data. Strict confidentiality of 
any identifiable patient data was maintained, and all ethical guidelines were followed during the 
course of this project.   
Essential V: Advocacy for Health Care Policy 
 The DNP critically analyzes health policy proposals, demonstrates leadership in the 
development and implementation of policies, as well as educates and advocates for the nursing 
profession (AACN, 2006). Although no formal policy was changed through this project, 
education and advocacy for implementation of evidence-based policies at an organizational level 
were performed through this project. Additionally, this essential was met through attendance of 
Advocacy Day and meeting with state legislatures regarding policies that advocate for the 
expansion of the advanced practice registered nurse role.  
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Essential VI: Interprofessional Collaboration 
 The DNP exhibits leadership in collaborating between multiple healthcare specialties to 
create change in complex healthcare delivery systems (AACN, 2006). This essential was met 
through collaborating with multiple different healthcare roles in the development, 
implementation, and evaluation of this project. Collaborative healthcare professionals included 
RNs, managers, CNSs, educators, pharmacists, providers, IT/quality improvement data 
specialists, and statisticians. Incorporating a diverse collaborative group allowed for better 
understanding of the current practice, assessing barriers, and evaluating necessary practice 
changes.   
Essential VII: Clinical Prevention and Population Health 
 The DNP can analyze scientific data, synthesize concepts, develop/implement/evaluate 
interventions, and address gaps in care related to clinical prevention and population health 
(AACN, 2006). This project was focused on prevention for better population health. Sepsis is a 
leading cause of hospital-related deaths – this not only causes poor patient outcomes but also 
costs both the patient and the healthcare system substantial amounts of money. Validating a tool 
in use to ensure it is actually detecting sepsis rates sooner allows the hospital to evaluate how 
well they are doing with detecting and treating sepsis in their patients.  
Essential VIII: Advanced Nursing Practice  
 This essential encompasses the competencies that are necessary for all DNP-prepared 
specialties and act as a foundation for DNP practice. The DNP can: conduct comprehensive and 
systematic assessments in complex situations; design, implement and evaluate interventions; 
develop and sustain relationships with patients and other professionals in order to provide 
optimal care outcomes; and demonstrate systems thinking in order to improve patient outcomes 
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(AACN, 2006). This project covered all of these competencies. An organizational assessment of 
current practice was performed and systems thinking was used to design and implement a plan to 
evaluate the sepsis screening tool for evidence-based use. In order to carry out this project, many 
relationships with various stakeholders, primarily consisting of the sepsis steering committee 
members, were developed and sustained. 
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Appendix B 
Project Organization IRB Determination Letter 
Appendix B. Available upon request.  
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Appendix C 
GVSU IRB Determination Letter 
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Appendix D 
Appendix D. SWOT Analysis of the Pediatric Sepsis Screening Tool at CHM. 
 
 
 
 
 
 
Strengths 
• Interprofessional Collaboration 
• Sepsis Steering Committee  
• Collaboration with CHA 
• Collaboration within the organization of 
CHM in other populations (i.e. adult and 
neonatal) 
• Best Children’s Hospital in 6 specialty 
areas for 2018 
 
Weaknesses 
• Current paper screening tool 
• Tension with RNs over adding another 
task 
• Collating paper documents in order to 
generate reports 
• Inaccurate timestamp on paper tool 
• RN confusion and increased errors related 
to many changes occurring at once 
Opportunities 
• CHA sepsis collaborative 
• Working alongside new EHR to 
implement a clinical decision support tool 
within the EHR 
• Customization options within the new 
EHR 
Threats 
• Deadlines within CHA collaborative 
• Difficulty retrieving data from old EHR at 
CHM 
• Current lack of evidence to support a 
pediatric sepsis screening tool 
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Appendix E 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix E. PRISMA Flow diagram of search selection process. 
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Appendix F 
Author (Year) 
Purpose 
Design (N) Inclusion 
Criteria 
Intervention 
vs 
Comparison 
Results Conclusion 
Davis (2017) Provide 
update of 2007 
American College of 
Critical Care Medicine 
to form guidelines for 
the newborn and 
pediatric age groups 
Septic Shock. 
Systematic 
Review  
(N=143) 
2006 - 2014, 
neonatal and 
pediatric 
population, 
sepsis tool 
monitoring 
guidelines  
Older 
guidelines 
versus newer 
guidelines 
analyzing 
compliance, 
earlier 
identification, 
and earlier 
intervention 
Improved 
compliance 
reduced hospital 
mortality from 
4% to 2%. 
Improved 
mortality with 
compliance to 
first-hour and 
stabilization 
guideline 
recommendations 
Consider 
institution—
specific use of  
1) a recognition 
bundle 
containing trigger 
tool for rapid 
identification of 
patients with 
septic shock,  
2) resuscitation 
and stabilization 
bundle to help 
adherence to best 
practice 
principles 3) 
performance 
bundle to identify 
and overcome 
perceived 
barriers to best 
practice  
Lake (2014) 
Heart rate 
characteristics for 
monitoring early 
detection of late-onset 
neonatal sepsis    
RCT 
(N=1489) 
2004 - 2010 
neonates used 
a screening 
tool indicator 
to monitor 
neonatal 
sepsis 
Compared 
data from 
prior sepsis 
without heart 
rate 
monitoring to 
current data  
Predictive value 
affirmed good 
calibration, 
(increase of 
0.03), continuous 
net 
reclassification 
index (0.39) and 
integrated 
discrimination 
index (0.01) 
 
Compares well to 
other risk factors 
Heart rate 
characteristics 
monitoring is 
validated risk 
marker for sepsis 
in the NICU  
Paliwoda (2015) 
Examine use and 
efficacy of early 
warning tools (EWTs) 
Systematic 
Review 
(N=21) 
2004 – 2014 
systematic 
review, 
neonatal 
Newly 
developed 
EWT and 
standard 
Of the 19 infants 
who received an 
intervention, nine 
were identified 
There is a need 
for validity and 
effectiveness of 
use of EWTs in 
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in identifications of 
deterioration in 
neonates.  
population, 
used a 
screening tool 
to monitor 
neonatal 
deterioration  
observation 
tool in 
identifying 
early 
deterioration 
of neonates 
using EWT 
(47%) 
neonatal 
population  
Roney (2015) 
Evaluate current 
research on modified 
early warning scoring 
(MEWS) system tools 
to prevent failure to 
rescue in hospitalized 
adult medical-
surgical/telemetry 
patient. 
Systematic 
Review 
(N=18) 
Literature 
prior to 2014, 
systematic 
review, adult 
screening 
tools 
monitoring 
sepsis 
MEWS versus 
other 
standardized 
screening 
tools 
6 of 18 (33%) 
reported 
mortality 
predictive value 
and/or reduction,  
3 (17%) 
measured impact 
on emergency 
calls, and 4 
(39%) reported 
impact on 
mortality and 
rapid response 
team utilization 
Development of 
all-cause illness 
screening tools, 
including sepsis, 
needed.  
 
Clinical picture, 
when with 
scoring tools, 
may assist 
clinical decision-
making leading 
to improved 
outcomes and 
decreased failure 
to rescue 
Appendix F. Articles included in review with author, year, purpose, design, inclusion, results, 
conclusions. 
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Appendix G 
 
Appendix G. Center for Disease Control and Prevention’s Infectious Disease Framework (CDC, 
2011). Retrieved from https://www.cdc.gov/oid/docs/ID-Framework.pdf 
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Appendix H 
Administrative approval to conduct this project at the project organization 
Appendix H. Available upon request.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINAL DEFENSE 
  
   
47 
Appendix I 
 
Appendix I. Institute for Healthcare Improvement’s Plan Do Study Act Implementation Model 
(IHI, 2017). Retrieved from 
http://www.ihi.org/resources/Pages/Tools/PlanDoStudyActWorksheet.aspx 
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Appendix J 
 
Item 
Measurement 
Level 
How Time 
Measured/Assessed 
When 
Measured/Assessed 
 
 
 
 
 
 
System   
Did patient go 
to ICU? 
Yes, No 
(Categorical) 
Time (Military) After sepsis diagnosis 
occurred 
Time to ICU 
Minutes 
(Numeric) 
Time (Military) From when sepsis was 
declared from tool 
Time to 
antibiotic 
initiation 
Minutes 
(Numeric) 
Time (Military) From when sepsis was 
declared from tool 
Time to fluid 
bolus 
Minutes 
(Numeric) 
Time (Military) From when sepsis was 
declared from tool 
Time to 
“trigger” tool 
Minutes 
(Numeric) 
Time (Military) From admission to 
when sepsis was 
declared from tool 
Time to sepsis 
huddle 
Minutes 
(Numeric) 
Time (Military) From when sepsis was 
declared from tool 
 
 
 
Pediatric 
patient  
Tachycardia* Numeric Time (Military)  
 
 
At time of SEPSIS 
Huddle** 
Bradycardia* Numeric Time (Military) 
Hypotension* Numeric Time (Military) 
Fever* 
Yes, No 
(Categorical) 
Time (Military) 
Hypothermia 
Yes, No 
(Categorical) 
Time (Military) 
Current use of 
Steroids 
Yes, No 
(Categorical) 
Time (Military) 
Altered Mental 
Status 
Yes, No 
(Categorical) 
Time (Military) 
Chills 
Yes, No 
(Categorical) 
Time (Military) 
Capillary Refill 
> 3 seconds 
Yes, No 
(Categorical) 
Time (Military) 
Mottled cool 
extremities 
Yes, No 
(Categorical) 
Time (Military) 
Neck Stiffness 
Yes, No 
(Categorical) 
Time (Military) 
"Flash" 
Capillary Refill 
< 1 second 
Yes, No 
(Categorical) 
Time (Military) 
Neutropenia 
(ANC <500) 
Yes, No 
(Categorical) 
Time (Military) 
Appendix J. Table of Measures. *See Appendix K. **See Appendix L.  
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Appendix K 
 
Appendix K. Organization’s definition of hypotension, tachycardia, and bradycardia to inform 
completing of screening tool for sepsis 
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Appendix L 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix L. Triggers for a sepsis huddle at project organization.    
 
 
 
 
Presence of 
tachycardia, 
bradycardia, OR 
hypotension 
Presence of fever, 
hypothermia, OR 
current use of steroids 
Yes 
Presence of hypotension, altered mental 
status, chills, capillary refill greater than 3 
seconds, mottled cool extremities, neck 
stiffness, OR “flash” capillary refill less 
than 1 second 
Yes 
Sepsis huddle initiated, 
and time is recorded 
on the sepsis screening 
paper tool 
Yes 
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Appendix M 
Appendix M. Evidence to support factors within the pediatric sepsis screening tool at CHM  
 
 
 
 
 
 
 
Pediatric Sepsis Screening Factor: Evidence to Support in Literature: 
Tachycardia Davis (2017); Randolph (2014) 
Bradycardia Davis (2017); Randolph (2014); Dellinger (2013) 
Hypotension Davis (2017); Randolph (2014); Dellinger (2013) 
Fever Davis (2017); Randolph (2014); Dellinger (2013) 
Hypothermia Davis (2017); Randolph (2014); Dellinger (2013) 
Current use of Steroids Dellinger (2013) 
Altered Mental Status Davis (2017); Sepanski (2014); Dellinger (2013) 
Chills CDC (2017); NHS UK (2016) 
Capillary Refill > 3 seconds Davis (2017); Sepanski (2014) 
Mottled cool extremities Dellinger (2013) 
Neck Stiffness CDC (2017); NHS UK (2016) 
"Flash" Capillary Refill < 1 second Dellinger (2013) 
Neutropenia (ANC <500) Sano (2017) 
FINAL DEFENSE 
  
   
52 
Appendix N 
Budget 
Doctor of Nursing Practice Project Financial Operating Plan   
Sepsis Screening Tool Assessment at a Freestanding Children’s Hospital in the Midwest 
   
Revenue   
Project Manager Time (in-kind donation) 6,200.00 
Consultations   
Statistician (in-kind donation) 100.00 
Cost mitigation    
Prevention of 1 case of Severe Sepsis-related ventilator care / per year 40,878* 
Prevention of 1 case of Severe Sepsis that required a ventilator for < 96 hours / per year 11, 794* 
TOTAL INCOME 58,972.00 
    
Expenses   
Project Manager Time (in-kind donation) 6,200.00 
Team Member Time:   
Clinical Nurse Specialist (1) 2,000.00 
Registered Nurse (1) 3,500.00 
Consultations   
Statistician (in-kind donation) 100.00 
Laptop 1,200.00 
Cost of print/copy/fax 3,672.00 
TOTAL EXPENSES 16,672.00 
    
Net Operating Plan 42,300.00 
*O’Brien & CDC. (2015). The cost of sepsis. Retrieved from 
https://blogs.cdc.gov/safehealthcare/the-cost-of-sepsis/ 
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Appendix O 
Timeline 
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Appendix P 
Characteristic  
 Mean (SD) range 
Age 7.05 (6.05) 0.02-20.57 
 % (n) 
Gender  Female 44.3% (74)  
Male 55.7% (93)  
Race Caucasian 60.5% (101) 
African American 16.2% (27) 
Other 17.4% (29) 
Not Documented 6% (10) 
Ethnicity Hispanic 13.8% (23) 
Non-Hispanic 79% (132) 
Not Documented 7.2% (12) 
Hospital Acquired Sepsis Yes 6% (10) 
No 94% (157) 
 Median (IQR) 
Length of stay 10.05 (4.94 –19.14) 
Appendix P. Age, gender, race, ethnicity, and length of stay of patients in audit 
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Appendix Q 
Audit of clinically derived 
time zero 
Tool flagged % (n) 
Before  10.8% (18) 
At 24.0% (40) 
After  65.3% (109) 
 
 
Appendix Q. Clinical status flagged before, at, and after clinically derived times zero overall 
 
 
 
 
 
 
 
10.8%
24.0%
65.3%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
Before At After
Percentage Tool Flagged  Before, At, and After CDTZ
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Appendix R 
High risk factor % (n) 
 Yes No Not documented/unclear 
CNS dysfunction 42.5% (71) 54.5% (91) 3% (5) 
Leukopenia, Leukocytosis, or 
Bands >10%  
in the last 12 hours 
40.1% (67) 16.2% (27) 43.7% (73) 
Central Line  28.7% (48) 42.5% (71) 28.7% (48) 
Immunodeficiency 19.8% (33) 21.6% (36) 58.7% (98) 
Malignancy 15.6% (26) - 84.4% (141) 
Patient ≤ 60 days old 9.6% (16) 90.4% (151) - 
Bone Marrow or Solid Organ 
Transplant 
7.8% (13) 1.8% (3) 90.4% (151) 
Asplenia 1.20% (2) - 98.8% (165) 
Appendix R. High risk factor frequency occurrence documented in health record 
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Appendix S 
Clinical problem  Median (IQR) n 
Neutropenia (ANC <500) 35.57 (0.0 – 717.42) 47 
Appendix S. Abnormal high-risk condition clinical problems 
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Appendix T 
 Median (IQR)  
Time (hours) Before After Difference 
To ICU 4.92 (1.30 – 12.0) 2.68 (1.58 – 6.30) 2.24 
To antibiotic 1.47 (0.35 – 5.37) 1.76 (0.78 – 4.45) -0.29 
To fluid 1.33 (0.02 – 121.8) 1.16 (0.47 – 2.70) 0.17 
 Mean (SD) p-Value 
Overall -0.65 (23.72) 1.35 (6.42) 0.19 
 
 
Appendix T. Time from status change to ICU admission, antibiotic, and fluid 
 
 
 
 
 
 
4.92
1.47 1.33
2.68
1.76
1.16
0
1
2
3
4
5
6
To ICU To antibiotic To fluid
Ho
ur
s
Median Time from CDTZ to ICU, ABX, and Fluid initiation Before 
and After Tool Implementation
Before After
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Appendix U 
Status % (n) 
 Yes No Not 
Documented  
Tachycardia 65.3% (109) 31.7% (53) 3.0% (5) 
Fever 62.9% (105)  27.0% (45) 10.2% (17) 
Altered Mental Status 38.9% (65) 32.9% (55) 28.1% (47) 
Capillary Refill >3 
seconds 
18.6% (31) 42.5% (71) 38.9% (65) 
Hypothermia  18.0% (30)  71.9% (120) 10.2% (17) 
Mottled/Cool 
Extremities 
16.8% (28) 
cool 
2.4% (4) 
mottled 
3.6% (6) 
both 
44.9% (75) 32.3% (54) 
Neutropenia 11.4% (19) 16.2% (27) 72.5% (121) 
Hypotension 9% (15) 70% (117) 21.0% (35) 
Currently on Steroids 8.4% (14) 41.9% (70) 49.7% (83) 
Chills 8.4% (14) 8.4% (14) 83.2% (139) 
Neutropenia  
(ANC <500) >7 days 
2.4% (4) 17.4% (29) 80.2% (134) 
Neck Stiffness 0.6% (1)  71.3% (119) 28.1% (47) 
Flash Capillary Refill 
<1 second 
- 57.5% (96) 42.5% (71) 
Bradycardia 0.6% (1) 96.2% (161)* 3.0% (5) 
*4 of 161 patients or 2.4% of the 96.2% were above the age range 
 
 
Appendix U. Clinical status symptom/sign that flagged the tool 
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Appendix V 
Age groups Mean (SD) n 
 Heartrate Fever Systolic Diastolic 
0 – 1 Months 181.9 (24.0) 7 36.2 (1.7) 8 95.3 (20.2) 4 58.3 (24.0) 4 
>1 – 2 Months 178.8 (36.1) 9 36.7 (3.31) 8 91.2 (14.7) 5 53.2 (12.2) 5 
3 – 11 Months 
 
154.2 (30.0) 13  95.8 (21.0) 10 51.9 (8.8) 10 
1 – 3 Years 176.0 (28.3) 44 39.0 (1.6) 39 95.9 (20.1) 35 53.1 (22.3) 35 
4 – 11 Years 137.5 (35.0) 47  99.6 (19.0) 43 54.5 (16.4) 43 
>12 Years 127.6 (26.5) 42  106.4 (19.1) 35 56.2 (16.7) 35 
 Median (IQR) 
3-11 Months  39.0 (35.9 – 40.5) 11   
4 – 11 Years  38.9 (32.1 – 39.5) 47   
>12 Years  38.8 (33.7 – 40.2) 37   
Appendix V. For patients in age range  
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Appendix W 
High-Risk Factor or Status % (n) 
 
 Yes No Not 
Documented 
Tachycardia 84.5% (49)  15.5% (9) - 
Fever 79.3% (46) 20.7% (12) - 
Altered Mental Status 65.5% (38) 24.1% (14) 10.3% (6) 
CNS dysfunction 51.7% (30) 46.6% (27) 1.7% (1) 
Central Line  36.3% (21)  41.4% (24) 22.4% (13) 
Capillary Refill >3 seconds 29.3% (17) 41.4% (24) 
 
29.3% (17) 
Leukopenia, Leukocytosis, or 
Bands >10%  
in the last 12 hours 
25.9% (15)  27.6% (16) 46.6% (27) 
Hypotension 24.1% (14) 53.5% (31) 22.4% (14) 
Hypothermia  20.7% (12) 79.3% (46) - 
Malignancy 19% (11)  - 81.0% (47) 
Immunodeficiency 19% (11)  19% (11)  62.1% (36) 
Neutropenia 15.5% (9)  8.6% (5) 75.9% (44) 
Bone Marrow or Solid Organ 
Transplant 
12.1% (7)  3.5% (2) 84.5% (49) 
Currently on Steroids 10.3% (6)  37.9% (22) 51.7% (30) 
Chills 10.3% (6)  6.9% (4) 82.8% (48) 
Patient ≤ 60 days old 6.9% (4)  93.1% (54) - 
Neutropenia  
(ANC <500) >7 days 
5.2% (3) 8.6% (5) 
 
86.2% (50) 
Mottled/Cool Extremities Both 5.2% (3) 44.8% (26) 17.2% (10) 
Cool 27.6% (16) 
Mottled 5.2% (3) 
Neck Stiffness 1.7% (1) 74.1% (43) 24.1% (14) 
Bradycardia 1.7% (1)  93.1% (54) - 
5.2% (3) Above 
age range 
Flash Capillary Refill <1 second - 69.0% (40) 
 
31.0% (18) 
Asplenia - - 100% (58) 
Appendix W. Percentage of factors that flagged tool before or at clinically derived time zero  
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Appendix X 
 
Appendix X. Percentage of factors that flagged tool before or at clinically derived time zero  
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Objectives for Presentation
1. Present the clinical problem within the 
context of the organizational assessment
2. Review evidence supporting solution
3. Review the QI project and results
4. Discuss project sustainability and 
dissemination
5. Reflect on DNP Essentials
Introduction
• Sepsis is a major contributor to morbidity and 
mortality (Schlapbach & Kissoon, 2018). 
• The prevalence of pediatric severe sepsis in 
critically ill patients is 8.2% globally, with a 
hospital mortality rate of 25% (Weiss et al., 
2015).
Introduction
• Tools for predicting sepsis in pediatrics:
– Poor predictive ability
– Not validated 
• (Schlapbach & Kissoon, 2018). 
• Systemic inflammatory response syndrome (SIRS) used to 
define and predict sepsis in pediatrics.
– Criterion had low specificity
– Limited use to clinicians 
• (Schlapbach & Kissoon, 2018). 
• An evidence-based pediatric sepsis screening tool is needed
– To initiate early diagnosis
– To treat earlier 
Assessment of Organization
• Systematic process to evaluate the workflow 
and factors that affect organizational 
performance (Reflect & Learn, n.d.).
• Purpose of assessment:
– Use a framework to analyze organization.
Framework: The Canadian Foundation for 
Healthcare Improvement (CFHI) 
Engage front-line 
managers and 
providers
Building 
organizational 
capacity
Focusing on 
population needs
Creating 
supportive policies 
and incentives
Engaging patients
Promoting 
evidence-based 
decision-making
HEALTHCARE 
IMPROVEMENT
(CFHI, 2014)
IRB Approvals
Site IRB available upon request.
Stakeholders
• Site mentors
• Healthcare providers i.e., physicians, physician 
assistants, nurse practitioners, and nurses
• Patients
• Sepsis Steering Committee
• Electronic health record technical employees
• Organization
 Strengths 
• Interprofessional Collaboration 
• Sepsis Steering Committee  
• Collaboration with CHA 
• Collaboration within the organization of 
CHM in other populations (i.e. adult and 
neonatal) 
• Best Children’s Hospital in 6 specialty 
areas for 2018 
 
Weaknesses 
• Current paper screening tool 
• Tension with RNs over adding another 
task 
• Collating paper documents in order to 
generate reports 
• Inaccurate timestamp on paper tool 
• RN confusion and increased errors related 
to many changes occurring at once 
Opportunities 
• CHA sepsis collaborative 
• Working alongside new EHR to 
implement a clinical decision support tool 
within the EHR 
• Customization options within the new 
EHR 
Threats 
• Deadlines within CHA collaborative 
• Difficulty retrieving data from old EHR at 
CHM 
• Current lack of evidence to support a 
pediatric sepsis screening tool 
SWOT
Clinical Practice Questions
1. “Did the current pediatric sepsis screening 
tool in use at CHM identify patients at risk for 
sepsis?” 
2. “Did the sepsis screening tool use initiate 
intervention (i.e. fluid boluses and antibiotics) 
sooner than when compared to no tool?”
Literature Review
• Purpose: Examine tools that identify pediatric 
sepsis.
• Aim: Answer the questions:
– “Will a sepsis screening tool adequately aid in 
early identification of pediatric sepsis?”
– “What are the specific constructs needed for a 
pediatric sepsis screening tool?”
– “Is there evidence to support use of a pediatric 
sepsis screening tool?”
Review Method
• CINAHL, PubMed, Web of Science search:
– English in 2013 to 2018. 
• Keywords: 
– Sepsis
– Tool
– Pediatric, neonate, and child
– Early warning score.
• Inclusion Criteria:
– Meta analyses, randomized control trials (RCT), and 
systematic reviews
– Peer-reviewed journals
Results: Literature Review
• Four papers met inclusion criteria.
– Three systematic reviews
– One RCT. 
• Analyzed screening: earlier detection of sepsis. 
– One examined heart rate activity in neonatal infants as 
a marker for neonatal sepsis 
• (Lake, Fairchild, & Moorman, 2014). 
– Three reviewed sepsis protocol screening tools for 
neonatal, pediatric, and adult populations
• (Davis et al., 2017; Roney et al., 2015; Paliwoda & New, 
2015). 
PRISMA Figure
Articles identified using 
keywords in CINAHL, 
PubMed, and Web of 
Science (N=243)
# of records screened 
after 9 duplicates were 
removed (n=234)
Records excluded after 
title and abstract 
reviewed due to not 
published in the past 5 
years or article not 
directly related to sepsis 
screening (n=214)
Full-text articles 
assessed for eligibility 
(n=20)
Full-text articles 
excluded for reasons 
pertaining to population, 
intervention, 
comparison, and 
outcome (n=16)
Studies included in 
this review (n=4)
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(Moher et al., 2015) 
Summary of Evidence
• Davis (2017) – a bundle containing trigger of tool 
for rapid identification of patients with sepsis 
• Lake (2014) – Heart rate monitoring a validated 
risk marker for sepsis 
• Paliwoda (2015) – Need for validity of sepsis 
screening tools
• Roney (2015) – Development of sepsis screening 
tool needed to improved outcomes
Results: Literature Review
• Evidence supports use of sepsis screening tool
• Designed for pediatric population
– Gold standard for clinical practice
– In the acute care hospital setting. 
• Use of tool has the potential to:
– Improve patient outcomes
– Reduce mortality rates.  
Evidence for Project
• Use of a screening tool for identification of sepsis and 
initiation of interventions improves patient outcomes. 
• Factors included in tool:
– Respiratory rate
– Heart rate
– Blood pressure
– Temperature (hypothermia or hyperthermia)
– Altered mental status
– Capillary refill
• (Davis et al., 2017; & Roney et al., 2015). 
Model to Examine Phenomenon: CDC’s 
Infectious Disease Framework (IDF) 
(CDC, 2011) 
Element 1. 
Strengthen public 
health 
fundamentals, 
including infectious 
disease surveillance, 
laboratory 
detection, and 
epidemiologic 
investigation. 
Element 2. 
Identify and 
implement high-
impact public 
health 
interventions to 
reduce infectious 
diseases. 
Element 3. 
Develop 
advanced 
policies to 
prevent, detect, 
and control 
infectious 
diseases. 
Project Plan
Project Purpose & Objectives
Purpose: Detect pediatric sepsis using a 
screening tool. 
– Current tool had expert review/content validity. 
– Tool needed construct validity 
Objectives:
1. Examined if tool detected sepsis when compared 
to before the tool was implemented
2. Examined time to intervention with tool 
compared to no tool
Design
• Quality Improvement project
– Validate a sepsis risk assessment tool
• The project:
1. Examined a cohort of patients diagnosed with 
severe sepsis prior to use of the tool. 
2. Evaluated if the tool identified risk for sepsis 
prior to the sepsis diagnosis occurring.
3. Time to interventions (fluid boluses,  
antibiotics) was examined comparing those 
who used screening tool to those who did not 
use the tool. 
Setting & Participants
• Setting: 
– Freestanding children’s hospital
– Midwest (CHM)
– Units: hematology, oncology, cardiology, 
respiratory, surgical, and behavioral health
• Participants: 
– Patients with severe sepsis diagnosis
Implementation Model
(IHI, 2017)
Implementation Strategy #1 
Readiness and Identifying Barriers
• Organizational Assessment and SWOT
• Discovered strategies for project: 
• Capturing and sharing knowledge
• Creating a learning collaborative
• Organizing implementation team meetings
• Using an implementation advisor 
• (Powell et al., 2015) 
Implementation Strategy #2 
Capturing and Sharing Knowledge Creating a 
Learning Collaborative
• CHM is part of sepsis collaborative
• Children’s Hospital Association (CHA). 
• Goal: reduce hospital-acquired severe sepsis and sepsis 
mortality by 75% by the year 2020 (CHA, 2018). 
• By joining this collaborative:
• CHM part of all-teach, all-learn interdisciplinary team
• Allowed to view research of what other hospitals are 
doing to see what works. 
Implementation Strategy #3 
Organizing Implementation Team Meetings & 
Using an Implementation Advisor 
• CHM created a sepsis steering committee
– Driving force for organization
– Appointed an implementation advisor to direct the 
group meetings
Implementation Strategy #4 
Re-Examination & Ongoing Consultation
• Purposely re-examined implementation:
– Of risk-assessment tool
– CHM initially implemented the risk assessment 
tool without first ensuring it was evidence-based. 
• Provided ongoing consultation with CHM
– Findings in literature
– Results of chart audits
– Results of risk assessment tool validation. 
Implementation Strategy #5: 
Develop Tools for Quality Monitoring
• Developed tools for quality monitoring
– Measures/codebook for chart audits. 
• Distributed to CHM
– After project completion
– For use in
• Organization
• Collaborative 
Evaluation & Measures
Item
Measurement Level How Time Measured/Assessed When Measured/Assessed
System 
Did patient go to ICU?
Yes, No (Categorical) Time (Military) After sepsis diagnosis occurred
Time to ICU
Minutes (Numeric) Time (Military) From when sepsis was declared 
from tool
Time to antibiotic initiation
Minutes (Numeric) Time (Military) From when sepsis was declared 
from tool
Time to fluid bolus
Minutes (Numeric) Time (Military) From when sepsis was declared 
from tool
Time to “trigger” tool
Minutes (Numeric) Time (Military) From admission to when sepsis 
was declared from tool
Time to sepsis huddle
Minutes (Numeric) Time (Military) From when sepsis was declared 
from tool
Pediatric patient 
Tachycardia* Numeric Time (Military)
At time of SEPSIS Huddle**
Bradycardia* Numeric Time (Military)
Hypotension* Numeric Time (Military)
Fever* Yes, No (Categorical) Time (Military)
Hypothermia Yes, No (Categorical) Time (Military)
Current use of Steroids Yes, No (Categorical) Time (Military)
Altered Mental Status Yes, No (Categorical) Time (Military)
Chills Yes, No (Categorical) Time (Military)
Capillary Refill > 3 seconds
Yes, No (Categorical) Time (Military)
Mottled cool extremities
Yes, No (Categorical) Time (Military)
Neck Stiffness Yes, No (Categorical) Time (Military)
"Flash" Capillary Refill < 1 
second
Yes, No (Categorical) Time (Military)
Neutropenia (ANC <500)
Yes, No (Categorical) Time (Military)
Evaluation & Measures
Analysis Plan
• Compare pre-/post-tool audit
– Patients with severe sepsis diagnoses.
• Before use of the screening tool:
– When fluid boluses and antibiotics were given 
– Recorded vital signs to see if sepsis would have been 
identified sooner based on the items the tool evaluates. 
– Measure when sepsis was diagnosed
– How long before a patient with sepsis went to ICU
• Patients identified for sepsis by the screening tool
– Used to compare time to sepsis diagnosis
– Between pre-/post patients
Timeline 
Results
Characteristic
Mean (SD) range
Age 7.05 (6.05) 0.02-20.57
% (n)
Gender Female 44.3% (74) 
Male 55.7% (93) 
Race Caucasian 60.5% (101)
African American 16.2% (27)
Other 17.4% (29)
Not Documented 6% (10)
Ethnicity Hispanic 13.8% (23)
Non-Hispanic 79% (132)
Not Documented 7.2% (12)
Hospital Acquired 
Sepsis
Yes 6% (10)
No 94% (157)
Median (IQR)
Length of stay 10.05 (4.94 –19.14)
Results
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Results
High risk factor % (n)
Yes No Not documented/unclear
CNS dysfunction 42.5% (71) 54.5% (91) 3% (5)
Leukopenia, Leukocytosis, or 
Bands >10% 
in the last 12 hours
40.1% (67) 16.2% (27) 43.7% (73)
Central Line 28.7% (48) 42.5% (71) 28.7% (48)
Immunodeficiency 19.8% (33) 21.6% (36) 58.7% (98)
Malignancy 15.6% (26) - 84.4% (141)
Patient ≤ 60 days old 9.6% (16) 90.4% (151) -
Bone Marrow or Solid Organ 
Transplant
7.8% (13) 1.8% (3) 90.4% (151)
Asplenia 1.20% (2) - 98.8% (165)
Results
Clinical problem Median (IQR) 
N = 47
Neutropenia (ANC <500) 35.57 
(0.0 – 717.42)
Results
4.92
1.47
1.33
2.68
1.76
1.16
0
1
2
3
4
5
6
To ICU To antibiotic To fluid
H
ou
rs
Median Time from CDTZ to ICU, ABX, and Fluid initiation Before and After Tool 
Implementation
Before After
Results *4 of 161 patients or 2.4% of the 96.2% were above the age range
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
120.0%
Ta
ch
yca
rdi
a
Fe
ver
Al
ter
ed
 M
en
tal
 St
atu
s
Ca
pil
lar
y R
efi
ll >
3 s
eco
nd
s
Hy
po
the
rm
ia
Co
ol 
Ex
tre
mi
tie
s
Mo
ttle
d E
xtr
em
itie
s
Bo
th 
Ex
tre
mi
tie
s
Ne
utr
op
en
ia
Hy
po
ten
sio
n
Cu
rre
ntl
y o
n S
ter
oid
s
Ch
ills
Ne
utr
op
en
ia
(A
NC
 <5
00
) >
7 d
ay
s
Ne
ck
 St
iffn
ess
Fla
sh 
Ca
pil
lar
y R
efi
ll <
1 s
eco
nd
Br
ady
car
dia
Clinical Status Symptom/Sign That Flagged The Tool Overall 
Yes No Not Documented
Results
Age groups Mean (SD) n
Heartrate Fever Systolic Diastolic
0 – 1 Months 181.9 (24.0) 7 36.2 (1.7) 8 95.3 (20.2) 4 58.3 (24.0) 4
>1 – 2 Months 178.8 (36.1) 9 36.7 (3.31) 8 91.2 (14.7) 5 53.2 (12.2) 5
3 – 11 Months 154.2 (30.0) 13 95.8 (21.0) 10 51.9 (8.8) 10
1 – 3 Years 176.0 (28.3) 44 39.0 (1.6) 39 95.9 (20.1) 35 53.1 (22.3) 35
4 – 11 Years 137.5 (35.0) 47 99.6 (19.0) 43 54.5 (16.4) 43
>12 Years 127.6 (26.5) 42 106.4 (19.1) 35 56.2 (16.7) 35
Median (IQR)
3-11 Months 39.0 (35.9 – 40.5) 11
4 – 11 Years 38.9 (32.1 – 39.5) 47
>12 Years 38.8 (33.7 – 40.2) 37
Results
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Discussion
• Project found that the current tool use at CHM to detect risk 
of sepsis needs further testing of validity and reliabilty. 
• Supported by the current state of the literature: 
– No evidence-based sepsis screening tools are tailored for 
pediatric populations
– Only content-reviewed factors to screen for when evaluating for 
sepsis in pediatrics 
– (Davis et al., 2017; Lake, Fairchild, & Moorman, 2014; 
Paliwoda & New, 2015 & Roney et al., 2015). 
• Creation and testing of a tool to detect risk of Sepsis is 
needed before a tool will be validated for evidence-based 
use.  
Key Findings
• This is a much-needed area of study à any 
research findings to add to the current state of 
literature aid in shaping a future tool validation.
• A decrease in median time to ICU transfer and 
fluid bolus initiation were found when comparing 
pre- to post- tool implementation. 
– This shows an improvement in a critical time-
sensitive component of treating sepsis that is 
dependent on initially detecting sepsis through a 
screening tool.  
Key Findings
• This study spoke to what the top clinical status 
signs/symptoms were in severe sepsis patients, 
– This is useful information when deciding where to go 
next in configuring a tool that has construct validity. 
• Finally, this project also was able to evaluate age-
specific parameters for clinical status 
signs/symptoms such as heart rate, fever, and 
blood pressure. 
– This information is also useful when determining next 
steps for a sepsis screening tool and could be used in 
future research. 
Limitations
• This project had a fairly short implementation period and 
small sample size. 
– Although 20 months of data were used, there were still only 167 
patients that met criteria of a severe sepsis diagnosis included in 
this project. 
– Due to this, SEM analysis was not able to be performed, which 
could have been an advantageous statistical analysis to run for 
this type of project. 
• Relatively small sample size of post-tool implementation 
patients (n=45). 
– Time constraints for data collection
– Not enough collated data on severe sepsis diagnosed patients
• Lack of current evidence in literature to support any 
pediatric sepsis screening tool, let alone this specific tool.  
Implications for Practice
• Top five clinical status that flagged the tool
– Tachycardia, fever, altered mental status, capillary 
refill in greater than 3 seconds, and hypothermia. 
– Most useful in identifying pediatric sepsis 
• Other factors may need to be considered
– Both systolic and diastolic blood pressure values
– Respirations
– Peripheral capillary oxygen saturation (Sp02)
• Consider combining risk assessment tools in 
the pediatric population into one cohesive tool
Conclusions
• CHM sought to validate a sepsis screening tool 
currently in use for evidence-based use. 
• Organizational Assessment and Literature Review 
Performed
• Two theoretical frameworks and one theoretical model 
were used to understand the phenomenon and conduct a 
plan to validate the sepsis screening tool. 
• Pre- and post-tool chart audits were performed to 
implement this tool validation plan. 
• Data collection occurred over two months including 
patients from January 2017 through August 2018. 
Conclusions
• Despite being unable to provide construct 
validity for this pediatric sepsis screening tool, 
individual factors within the tool were able to 
be evaluated and future studies should build 
upon this research in order to work towards 
validating a pediatric sepsis screening tool for 
evidence-based use. 
Resources & Budget
Doctor of Nursing Practice Project Financial Operating Plan
Sepsis Screening Tool Assessment at a Freestanding Children’s Hospital in the Midwest
Revenue
Project Manager Time (in-kind donation) 6,200.00
Consultations
Statistician (in-kind donation) 100.00
Cost mitigation 
Prevention of 1 case of Severe Sepsis-related ventilator care / per year 40,878*
Prevention of 1 case of Severe Sepsis that required a ventilator for < 96 hours / per year 11, 794*
TOTAL INCOME 58,972.00
Expenses
Project Manager Time (in-kind donation) 6,200.00
Team Member Time:
Clinical Nurse Specialist (1) 2,000.00
Registered Nurse (1) 3,500.00
Consultations
Statistician (in-kind donation) 100.00
Laptop 1,200.00
Cost of print/copy/fax 3,672.00
TOTAL EXPENSES 16,672.00
Net Operating Plan 42,300.00
*(O’Brien & CDC, 2015)
Sustainability Plan
• Sepsis steering committee chair
– Monitor the effectiveness of the screening tool.
• Sepsis screening tool was embedded in EHR.
– January 3, 2019
– Made for easier monitoring:
• Tool effectiveness
• Sepsis detection. 
Dissemination 
1) Tools for quality monitoring (table of measures and 
codebook used to conduct chart audits) and findings 
were distributed to CHM for use within the 
organization and collaborative. 
2) Findings presented at the student’s oral defense on 
April 8, 2019. 
3) Final project defense paper posted on Scholarworks 
4) Findings will be presented at the organization’s 
research council poster presentation on April 9, 2019
5) Findings will be presented to the sepsis steering 
committee at the May 6, 2019 meeting
The American Colleges of Nursing (AACN) 
requires proficiency from DNP students in the 
following 8 competencies which make up the 
foundation for advanced practice nursing roles. 
Each are reviewed on the following slides.
DNP Essentials Reflection
• Essential I: Scientific Underpinnings for Practice
– This essential was achieved through this project by performing a 
literature review and using the knowledge gained from this 
review to improve care. 
– Additionally, frameworks were utilized for implementing and 
guiding change. 
• Essential II: Organizational and Systems Leadership
– This essential was achieved through this project by evaluating a 
tool that enhances care provided to the pediatric population. 
– Furthermore, developing and evaluating cost-effectiveness is 
another aspect of this essential that was met by developing a 
budget for this project and monitoring the project’s cost 
effectiveness
DNP Essentials Reflection
• Essential III: Clinical Scholarship and Analytical Methods for 
Evidence-Based Practice
– This essential was achieved through this project by using analytic 
methods to evaluate literature regarding the best evidence for sepsis 
screening in pediatric populations. 
– The project included designing a process to evaluate the effectiveness 
of the current sepsis screening tool in place. 
– Furthermore, relevant findings were disseminated to improve practice 
guidelines for use of the tool. 
• Essential IV: Information Systems Technology
– This essential was met by utilizing and navigating two different EHRs 
to gather pre- and post-tool data. E-mail was used for communication 
with key stakeholders for progress updates and additional resources. 
– Excel was used for organizing and analyzing data. 
– Strict confidentiality of any identifiable patient data was maintained, 
and all ethical guidelines were followed during the course of this 
project.  
DNP Essentials Reflection
• Essential V: Advocacy for Health Care Policy
– Although no formal policy was changed through this project, education 
and advocacy for implementation of evidence-based policies at an 
organizational level were performed through this project. 
– Additionally, this essential was met through attendance of Advocacy 
Day and meeting with state legislatures regarding policies that advocate 
for the expansion of the advanced practice registered nurse role. 
• Essential VI: Interprofessional Collaboration
– This essential was met through collaborating with multiple different 
healthcare roles in the development, implementation, and evaluation of 
this project. 
– Collaborative healthcare professionals included RNs, managers, CNSs, 
educators, pharmacists, providers, IT/quality improvement data 
specialists, and statisticians. 
– Incorporating a diverse collaborative group allowed for better 
understanding of the current practice, assessing barriers, and evaluating 
necessary practice changes.  
DNP Essentials Reflection
• Essential VII: Clinical Prevention and Population Health
– This project was focused on prevention for better population health. 
– Sepsis is a leading cause of hospital-related deaths – this not only causes 
poor patient outcomes but also costs both the patient and the healthcare 
system substantial amounts of money. 
– Validating a tool in use to ensure it is actually detecting sepsis rates 
sooner allows the hospital to evaluate how well they are doing with 
detecting and treating sepsis in their patients. 
• Essential VIII: Advanced Nursing Practice 
– This essential encompasses the competencies that are necessary for all 
DNP-prepared specialties and act as a foundation for DNP practice. 
– An organizational assessment of current practice was performed and 
systems thinking was used to design and implement a plan to evaluate the 
sepsis screening tool for evidence-based use. 
– In order to carry out this project, many relationships with various 
stakeholders, primarily consisting of the sepsis steering committee 
members, were developed and sustained 
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